Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.7K
The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

979
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979
Acute Pharyngitis01:30

Acute Pharyngitis

5.1K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deficient neutrophil responses early in influenza infection promote viral replication and pulmonary inflammation.

PLoS pathogens·2025
Same author

Senolytic treatment attenuates immune cell infiltration without improving IAV outcomes in aged mice.

Aging cell·2025
Same author

Deficiency of mitophagy mediator Parkin in aortic smooth muscle cells exacerbates abdominal aortic aneurysm.

bioRxiv : the preprint server for biology·2024
Same author

Deficiency in the mitophagy mediator Parkin accelerates murine skin allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2024
Same author

Effects of Obstructive Sleep Apnea on Airway Immunity and Susceptibility to Respiratory Infections.

Sleep medicine clinics·2024
Same author

Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice.

The Journal of clinical investigation·2023
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.3K

Postviral Complications: Bacterial Pneumonia.

Jason E Prasso1, Jane C Deng2

  • 1Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 37-131, Los Angeles, CA 90095, USA.

Clinics in Chest Medicine
|February 5, 2017
PubMed
Summary
This summary is machine-generated.

Secondary bacterial pneumonia following viral infections poses significant health risks. Identifying high-risk individuals and exploring new immunologic therapies are crucial for better prevention and treatment strategies.

Keywords:
Bacterial pneumoniaInfluenzaInnate immunityInterferonsRespiratory viruses

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.6K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Secondary bacterial pneumonia is a major complication of viral respiratory infections, contributing significantly to illness and death.
  • Current prevention (influenza vaccination) and treatment (antibiotics/antivirals) options for these secondary infections are limited.
  • Understanding the complex interplay between viral factors, bacterial factors, and host immune responses is essential.

Purpose of the Study:

  • To highlight the urgent need for novel strategies to identify individuals with influenza at higher risk for developing secondary bacterial pneumonias.
  • To emphasize the necessity of further research into the immunologic mechanisms underlying these secondary infections.
  • To explore potential new therapeutic targets for secondary bacterial pneumonia.

Main Methods:

  • This study is a review and synthesis of current knowledge on viral-bacterial interactions in pneumonia.
  • It analyzes existing data on host immune responses during viral respiratory infections.
  • It discusses limitations in current diagnostic and therapeutic approaches.

Main Results:

  • Viral infections compromise host defenses, increasing susceptibility to bacterial pathogens.
  • Specific viral and bacterial factors, along with host immune status, mediate this susceptibility.
  • Current risk identification and treatment strategies are insufficient to address the full scope of the problem.

Conclusions:

  • There is a critical need for improved methods to identify individuals at high risk of secondary bacterial pneumonia after viral infections.
  • Further investigation into the immunologic pathways involved is warranted.
  • Discovering new therapeutic targets could lead to more effective interventions against this serious condition.